Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience
Open accessThe DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Abstract
The stagnation in drug development for schizophrenia highlights the need for better translation between basic and clinical research. Understanding the neurobiology of schizophrenia presents substantial challenges but a key feature continues to be the involvement of subcortical dopaminergic dysfunction in those with psychotic symptoms. Our contemporary knowledge regarding dopamine dysfunction has clarified where and when dopaminergic alterations may present in schizophrenia. For example, clinical studies have shown patients with schizophrenia show increased presynaptic dopamine function in the associative striatum, rather than the limbic striatum as previously presumed. Furthermore, subjects deemed at high risk of developing schizophrenia show similar presynaptic dopamine abnormalities in the associative striatum. Thus, our view of subcortical dopamine function in schizophrenia continues to evolve as we accommodate this newly acquired information. However, basic research in animal models has been slow to incorporate these clinical findings. For example, psychostimulant-induced locomotion, the commonly utilised phenotype for positive symptoms in rodents, is heavily associated with dopaminergic activation in the limbic striatum. This anatomical misalignment has brought into question how we assess positive symptoms in animal models and represents an opportunity for improved translation between basic and clinical research. The current review focuses on the role of subcortical dopamine dysfunction in psychosis and schizophrenia. We present and discuss alternative phenotypes that may provide a more translational approach to assess the neurobiology of positive symptoms in schizophrenia. Incorporation of recent clinical findings is essential if we are to develop meaningful translational animal models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders(DSM)
(2008) · Encyclopedia of Counseling · doi:10.4135/9781412963978.n182 · Cited by 10,830
Kapur, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.13 · Cited by 2,813
Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging
Behrens, T. E. J., Johansen-Berg, H., Woolrich, M. W., Smith, S. M., Wheeler-Kingshott, C. A. M., Boulby, P. A., Barker, G. J., Sillery, E. L., Sheehan, K., Ciccarelli, O., et al. (2003) · Nature Neuroscience · doi:10.1038/nn1075 · Cited by 2,330
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Balleine, B. W., & O'Doherty, J. P. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.131 · Cited by 1,775
Kelly, P. H., Seviour, P. W., & Iversen, S. D. (1975) · Brain Research · doi:10.1016/0006-8993(75)90233-4 · Cited by 1,731
Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291
Koch, M. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00098-7 · Cited by 1,287
The basal ganglia: a vertebrate solution to the selection problem?
Redgrave, P., Prescott, T. J., & Gurney, K. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00319-4 · Cited by 1,199
Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression
Grace, A. A. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.57 · Cited by 1,166
Breier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154
The role of the dorsomedial striatum in instrumental conditioning
Yin, H. H., Ostlund, S. B., Knowlton, B. J., & Balleine, B. W. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04218.x · Cited by 1,099
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L. S., Weiss, R., Cooper, T. B., Mann, J. J., Van Heertum, R. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.8104 · Cited by 1,020
Brain Volumes in Schizophrenia: A Meta-Analysis in Over 18 000 Subjects
Haijma, S. V., Van Haren, N., Cahn, W., Koolschijn, P. C. M. P., Hulshoff Pol, H. E., & Kahn, R. S. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs118 · Cited by 1,012
Howes, O. D., Kambeitz, J., Kim, E., Stahl, D., Slifstein, M., Abi-Dargham, A., & Kapur, S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.169 · Cited by 967
Haber, S. N. (2016) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2016.18.1/shaber · Cited by 922
A functional neuroanatomy of hallucinations in schizophrenia
Silbersweig, D. A., Stern, E., Frith, C., Cahill, C., Holmes, A., Grootoonk, S., Seaward, J., McKenna, P., Chua, S. E., Schnorr, L., et al. (1995) · Nature · doi:10.1038/378176a0 · Cited by 906
Seeman, P., & Lee, T. (1975) · Science · doi:10.1126/science.1145194 · Cited by 869
Direct and indirect pathways of basal ganglia: a critical reappraisal
Calabresi, P., Picconi, B., Tozzi, A., Ghiglieri, V., & Di Filippo, M. (2014) · Nature Neuroscience · doi:10.1038/nn.3743 · Cited by 828
Increased Striatal Dopamine Transmission in Schizophrenia: Confirmation in a Second Cohort
Abi-Dargham, A., Gil, R., Krystal, J., Baldwin, R. M., Seibyl, J. P., Bowers, M., van Dyck, C. H., Charney, D. S., Innis, R. B., & Laruelle, M. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.6.761 · Cited by 803
Zahrt, J., Taylor, J. R., Mathew, R. G., & Arnsten, A. F. T. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08528.1997 · Cited by 796
Animal models of schizophrenia
Jones, C., Watson, D., & Fone, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01386.x · Cited by 771
Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
Howes, O. D., Montgomery, A. J., Asselin, M.-C., Murray, R. M., Valli, I., Tabraham, P., Bramon-Bosch, E., Valmaggia, L., Johns, L., Broome, M., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.514 · Cited by 744
Increased dopamine transmission in schizophrenia: relationship to illness phases
Laruelle, M., Abi-Dargham, A., Gil, R., Kegeles, L., & Innis, R. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00067-0 · Cited by 715
Urban, D. J., & Roth, B. L. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124803 · Cited by 668
Joel, D., & Weiner, I. (2000) · Neuroscience · doi:10.1016/s0306-4522(99)00575-8 · Cited by 614
Siskind, D., McCartney, L., Goldschlager, R., & Kisely, S. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.115.177261 · Cited by 601
Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity
Pijnenburg, A. J. J., Honig, W. M. M., Van Der Heyden, J. A. M., & Van Rossum, J. M. (1976) · European Journal of Pharmacology · doi:10.1016/0014-2999(76)90299-5 · Cited by 566
Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
Kegeles, L. S., Abi-Dargham, A., Frankle, W. G., Gil, R., Cooper, T. B., Slifstein, M., Hwang, D.-R., Huang, Y., Haber, S. N., & Laruelle, M. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.10 · Cited by 565
Static and Dynamic Cognitive Deficits in Childhood Preceding Adult Schizophrenia: A 30-Year Study
Reichenberg, A., Caspi, A., Harrington, H., Houts, R., Keefe, R. S. E., Murray, R. M., Poulton, R., & Moffitt, T. E. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09040574 · Cited by 556
Provocative tests with psychostimulant drugs in schizophrenia
Lieberman, J. A., Kane, J. M., & Alvir, J. (1987) · Psychopharmacology · doi:10.1007/bf00216006 · Cited by 532
Chudasama, Y., & Robbins, T. W. (2006) · Biological Psychology · doi:10.1016/j.biopsycho.2006.01.005 · Cited by 484
RAGOZZINO, M. E. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1401.013 · Cited by 482
Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies
Laruelle, M., & Abi-Dargham, A. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300405 · Cited by 461
Abi-Dargham, A., Krystal, J. H., Anjilvel, S., Scanley, B. E., Zoghbi, S., Baldwin, R. M., Rajeevan, N., Ellis, S., Petrakis, I. L., Seibyl, J. P., et al. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1550 · Cited by 405
Castner, S. A., Williams, G. V., & Goldman-Rakic, P. S. (2000) · Science · doi:10.1126/science.287.5460.2020 · Cited by 401
Sharp, T., Zetterström, T., Ljungberg, T., & Ungerstedt, U. (1987) · Brain Research · doi:10.1016/0006-8993(87)91416-8 · Cited by 395
Moore, H., Jentsch, J. D., Ghajarnia, M., Geyer, M. A., & Grace, A. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.01.003 · Cited by 359
van den Buuse, M. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp132 · Cited by 346
Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [ 18 F]-DOPA PET Imaging Study
Howes, O. D., Bose, S. K., Turkheimer, F., Valli, I., Egerton, A., Valmaggia, L. R., Murray, R. M., & McGuire, P. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010160 · Cited by 343
Demjaha, A., Egerton, A., Murray, R. M., Kapur, S., Howes, O. D., Stone, J. M., & McGuire, P. K. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.06.011 · Cited by 342
Pijnenburg, A. J. J., Honig, W. M. M., & Van Rossum, J. M. (1975) · Psychopharmacologia · doi:10.1007/bf00421062 · Cited by 330
Circuit-Based Corticostriatal Homologies Between Rat and Primate
Heilbronner, S. R., Rodriguez-Romaguera, J., Quirk, G. J., Groenewegen, H. J., & Haber, S. N. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.012 · Cited by 325
Contributions of the striatum to learning, motivation, and performance: an associative account
Liljeholm, M., & O’Doherty, J. P. (2012) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2012.07.007 · Cited by 317
Provocation of Schizophrenic Symptoms by Intravenous Administration of Methylphenidate
Janowsky, D. S. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750320023004 · Cited by 310
Reversal learning as a measure of impulsive and compulsive behavior in addictions
Izquierdo, A., & Jentsch, J. D. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2579-7 · Cited by 295
Howes, O., Bose, S., Turkheimer, F., Valli, I., Egerton, A., Stahl, D., Valmaggia, L., Allen, P., Murray, R., & McGuire, P. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.20 · Cited by 292
Striatal Presynaptic Dopamine in Schizophrenia, Part II: Meta-Analysis of [18F/11C]-DOPA PET Studies
Fusar-Poli, P., & Meyer-Lindenberg, A. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr180 · Cited by 262
Basal Ganglia Circuits for Reward Value–Guided Behavior
Hikosaka, O., Kim, H. F., Yasuda, M., & Yamamoto, S. (2014) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071013-013924 · Cited by 259
Egerton, A., Chaddock, C. A., Winton-Brown, T. T., Bloomfield, M. A. P., Bhattacharyya, S., Allen, P., McGuire, P. K., & Howes, O. D. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.017 · Cited by 253
The Significance of Age of Onset for Schizophrenia
DeLisi, L. E. (1992) · Schizophrenia Bulletin · doi:10.1093/schbul/18.2.209 · Cited by 243
The Bidirectional Associations Between Psychotic Experiences and DSM-IV Mental Disorders
McGrath, J. J., Saha, S., Al-Hamzawi, A., Andrade, L., Benjet, C., Bromet, E. J., Browne, M. O., Caldas de Almeida, J. M., Chiu, W. T., Demyttenaere, K., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15101293 · Cited by 235
Self-citationFusar-Poli, P., Howes, O. D., Allen, P., Broome, M., Valli, I., Asselin, M.-C., Grasby, P. M., & McGuire, P. K. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.77 · Cited by 234
Dopaminergic basis of salience dysregulation in psychosis
Winton-Brown, T. T., Fusar-Poli, P., Ungless, M. A., & Howes, O. D. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2013.11.003 · Cited by 231
Dopamine D2 receptors regulate the anatomical and functional balance of basal ganglia circuitry
Cazorla, M., de Carvalho, F. D., Chohan, M. O., Shegda, M., Chuhma, N., Rayport, S., Ahmari, S. E., Moore, H., & Kellendonk, C. (2014) · Neuron · doi:10.1016/j.neuron.2013.10.041 · Cited by 226
Abi-Dargham, A., van de Giessen, E., Slifstein, M., Kegeles, L. S., & Laruelle, M. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.12.007 · Cited by 213
Fusar-Poli, P., Howes, O. D., Allen, P., Broome, M., Valli, I., Asselin, M.-C., Montgomery, A. J., Grasby, P. M., & McGuire, P. (2011) · Molecular Psychiatry · doi:10.1038/mp.2009.108 · Cited by 207
Howes, O. D., Williams, M., Ibrahim, K., Leung, G., Egerton, A., McGuire, P. K., & Turkheimer, F. (2013) · Brain · doi:10.1093/brain/awt264 · Cited by 198
Corticostriatal Control of Goal-Directed Action Is Impaired in Schizophrenia
Morris, R. W., Quail, S., Griffiths, K. R., Green, M. J., & Balleine, B. W. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.06.005 · Cited by 197
The Treatment of Hallucinations in Schizophrenia Spectrum Disorders
Sommer, I. E. C., Slotema, C. W., Daskalakis, Z. J., Derks, E. M., Blom, J. D., & van der Gaag, M. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs034 · Cited by 194
Swanson, C. J., Heath, S., Stratford, T. R., & Kelley, A. E. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00043-9 · Cited by 176
Swerdlow, N. R., Caine, S. B., & Geyer, M. A. (1992) · Psychopharmacology · doi:10.1007/bf02245306 · Cited by 173
Schizophrenia: from dopaminergic to glutamatergic interventions
Laruelle, M. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.01.001 · Cited by 171
Corbit, L. H., & Janak, P. H. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07153.x · Cited by 165
Error-related negativity and correct response negativity in schizophrenia
Bates, A. T., Kiehl, K. A., Laurens, K. R., & Liddle, P. F. (2002) · Clinical Neurophysiology · doi:10.1016/s1388-2457(02)00154-2 · Cited by 163
Staton, D. M., & Solomon, P. R. (1984) · Physiological Psychology · doi:10.3758/bf03332184 · Cited by 161
Stone, J. M., Howes, O. D., Egerton, A., Kambeitz, J. P., Allen, P., Lythgoe, D. J., Tuura, R., McLean, M. A., Barker, G. J., & McGuire, P. K. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.05.034 · Cited by 152
Occurrence and co-occurrence of hallucinations by modality in schizophrenia-spectrum disorders
McCarthy-Jones, S., Smailes, D., Corvin, A., Gill, M., Morris, D. W., Dinan, T. G., Murphy, K. C., Anthony O′Neill, F., Waddington, J. L., Bank, A. S. R., et al. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.01.102 · Cited by 152
Special Section on Implications of CATIE: What CATIE Found: Results From the Schizophrenia Trial
Swartz, M. S., Stroup, T. S., McEvoy, J. P., Davis, S. M., Rosenheck, R. A., Keefe, R. S. E., Hsiao, J. K., & Lieberman, J. A. (2008) · Psychiatric Services · doi:10.1176/ps.2008.59.5.500 · Cited by 151
The multimodal connectivity of the hippocampal complex in auditory and visual hallucinations
Amad, A., Cachia, A., Gorwood, P. A. P. M., Pins, D., Delmaire, C., Rolland, B., Mondino, M., Thomas, P., & Jardri, R. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.181 · Cited by 149
Kelley, A. E., Gauthier, A. M., & Lang, C. G. (1989) · Behavioural Brain Research · doi:10.1016/s0166-4328(89)80005-1 · Cited by 148
McNally, J. M., & McCarley, R. W. (2016) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000244 · Cited by 144
Prepulse Inhibition of the Startle Reflex: A Window on the Brain in Schizophrenia
BRAFF, D. L. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_61 · Cited by 135
The neural underpinnings of cognitive flexibility and their disruption in psychotic illness
Waltz, J. A. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.005 · Cited by 122
Griffiths, K. R., Morris, R. W., & Balleine, B. W. (2014) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2014.00101 · Cited by 118
CNS stimulants as tools in the study of schizophrenia
Angrist, B., & van Kammen, D. P. (1984) · Trends in Neurosciences · doi:10.1016/s0166-2236(84)80062-4 · Cited by 117
van Schouwenburg, M., Aarts, E., & Cools, R. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791293097 · Cited by 113
Brain modules of hallucination: an analysis of multiple patients with brain lesions
Braun, C. M. J., Dumont, M., Duval, J., Hamel-Hébert, I., & Godbout, L. (2003) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0352 · Cited by 108
Rosell, D. R., Zaluda, L. C., McClure, M. M., Pérez-Rodríguez, M. M., Strike, K. S., Barch, D. M., Harvey, P. D., Girgis, R. R., Hazlett, E. A., Mailman, R. B., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.192 · Cited by 104
The NIMH-MATRICS project for developing cognition-enhancing agents for schizophrenia
Marder, S. R. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.1/smarder · Cited by 103
Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS
Swerdlow, N. R., Light, G. A., Sprock, J., Calkins, M. E., Green, M. F., Greenwood, T. A., Gur, R. E., Gur, R. C., Lazzeroni, L. C., Nuechterlein, K. H., et al. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2013.12.004 · Cited by 97
Aging-Related Dysfunction of Striatal Cholinergic Interneurons Produces Conflict in Action Selection
Matamales, M., Skrbis, Z., Hatch, R. J., Balleine, B. W., Götz, J., & Bertran‐Gonzalez, J. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.006 · Cited by 97
Boekhoudt, L., Omrani, A., Luijendijk, M. C. M., Wolterink‐Donselaar, I. G., Wijbrans, E. C., Plasse, G., & Adan, R. A. H. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.09.003 · Cited by 93
Howes, O. D., Shotbolt, P., Bloomfield, M., Daalman, K., Demjaha, A., Diederen, K. M. J., Ibrahim, K., Kim, E., McGuire, P., Kahn, R. S., et al. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr195 · Cited by 91
Saha, S., Scott, J. G., Varghese, D., & McGrath, J. J. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2010.12.012 · Cited by 87
Self-citationEyles, D., Feldon, J., & Meyer, U. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.6 · Cited by 85
Self-citationQuantifying over-activity in bipolar and schizophrenia patients in a human open field paradigm
Perry, W., Minassian, A., Henry, B. L., Kincaid, M. J., Young, J. W., & Geyer, M. A. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.04.032 · Cited by 85
George, M. S., Molnar, C., Grenesko, E. L., Anderson, B. S., Mu, Q., Johnson, K. A., Nahas, Z. H., Knable, M. B., FERNANDES, P. B., Juncos, J. L., et al. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.03.011 · Cited by 85
Kegeles, L. S., Slifstein, M., Xu, X., Urban, N., Thompson, J. L., Moadel, T., Harkavy-Friedman, J. M., Gil, R., Laruelle, M., & Abi-Dargham, A. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.05.027 · Cited by 82
Contribution of hippocampal region CA3 to consciousness and schizophrenic hallucinations
Behrendt, R. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.12.009 · Cited by 78
Kelleher, I., Murtagh, A., Clarke, M. C., Murphy, J., Rawdon, C., & Cannon, M. (2013) · Cognitive Neuropsychiatry · doi:10.1080/13546805.2012.682363 · Cited by 78
Gill, K. M., Cook, J. M., Poe, M. M., & Grace, A. A. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt236 · Cited by 72
Ertuğrul, A., Salancı, B. V., Başar, K., Oğuz, K. K., Demir, B., Ergün, E. L., Şentürk, S., Erbaş, B., Cila, A., & Uluğ, B. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2009.04.007 · Cited by 68
Lesions of the dorsomedial striatum disrupt prepulse inhibition
Ramsey, L. C. B., Xu, M., Wood, N. E., & Pittenger, C. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.01.041 · Cited by 67
Girgis, R. R., Snellenberg, J. X. V., Glass, A., Kegeles, L. S., Thompson, J. L., Wall, M. M., Cho, R. Y., Carter, C. S., Slifstein, M., Abi‐Dargham, A., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636120 · Cited by 65
Clozapine and GABA transmission in schizophrenia disease models
O'Connor, W. T., & O’Shea, S. D. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.01.005 · Cited by 63
PANTELIS, C., HARVEY, C. A., PLANT, G., FOSSEY, E., MARUFF, P., STUART, G. W., BREWER, W. J., NELSON, H. E., ROBBINS, T. W., & BARNES, T. R. E. (2004) · Psychological Medicine · doi:10.1017/s0033291703001569 · Cited by 62
D. Howes, O., Fusar-Poli, P., Bloomfield, M., Selvaraj, S., & McGuire, P. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799316217 · Cited by 62
Amelioration of ketamine-induced working memory deficits by dopamine D1 receptor agonists
Roberts, B. M., Seymour, P. A., Schmidt, C. J., Williams, G. V., & Castner, S. A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1840-9 · Cited by 61
Laurens, K. R., & Cullen, A. E. (2016) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-015-1151-x · Cited by 59
Connell, M., Betts, K. S., McGrath, J. J., Alati, R., Najman, J. M., Clavarino, A. M., Mamun, A. A., Williams, G. M., & Scott, J. G. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.06.009 · Cited by 56
Self-citationKesby, J. P., Cui, X., Burne, T. H. J., & Eyles, D. W. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00111 · Cited by 51
Self-citationDavid, H., Sissaoui, K., & Abraini, J. H. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.08.009 · Cited by 50
Alterations in the hippocampus and thalamus in individuals at high risk for psychosis
Harrisberger, F., Buechler, R., Smieskova, R., Lenz, C., Walter, A., Egloff, L., Bendfeldt, K., Simon, A. E., Wotruba, D., Theodoridou, A., et al. (2016) · Schizophrenia · doi:10.1038/npjschz.2016.33 · Cited by 50
The Glutamate Hypothesis of Schizophrenia: Neuroimaging and Drug Development
Egerton, A., & M. Stone, J. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112800784961 · Cited by 49
Larivière, S., Lavigne, K. M., Woodward, T. S., Gerretsen, P., Graff‐Guerrero, A., & Menon, M. (2017) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2017.03.005 · Cited by 49
The basal ganglia select the expected sensory input used for predictive coding
Colder, B. W. (2015) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2015.00119 · Cited by 46
Campbell, A., Villavicencio, A. T., Yeghiayan, S. K., Balikian, R. V., & Baldessarini, R. J. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00777-4 · Cited by 39
Bloemen, O. J. N., de Koning, M. B., Gleich, T., Meijer, J., de Haan, L., Linszen, D. H., Booij, J., & van Amelsvoort, T. A. M. J. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.04.015 · Cited by 37
Izaute, M., & Bacon, É. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300564 · Cited by 34
O’Tuathaigh, C. M. P., & Waddington, J. L. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.01.016 · Cited by 32
du Bois, T. M., Hsu, C., Li, Y., Tan, Y. Y., Deng, C., & Huang, X. (2008) · Neurochemical Research · doi:10.1007/s11064-007-9571-y · Cited by 29
The development of delusion revisited: A transdiagnostic framework
Poletti, M., & Sambataro, F. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.07.032 · Cited by 23
“God has sent me to you”: Right temporal epilepsy, left prefrontal psychosis
Arzy, S., & Schurr, R. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.04.022 · Cited by 23
Long-term pharmacoclinical follow-up in schizophrenic patients treated with risperidone
Aymard, N., Viala, A., Clément, M.-N., Jacquot, M., Vacheron, M.-N., Gauillard, J., & Caroli, F. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00218-x · Cited by 16
Viral vector strategies for investigating midbrain dopamine circuits underlying motivated behaviors
Pinto, D. F. C., & Lammel, S. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.02.006 · Cited by 14
Cited by
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders
Sorboni, S. G., Moghaddam, H. S., Jafarzadeh-Esfehani, R., & Soleimanpour, S. (2022) · Clinical Microbiology Reviews · doi:10.1128/cmr.00338-20 · Cited by 522
Metagenome-wide association of gut microbiome features for schizophrenia
Zhu, F., Ju, Y., Wang, W., Wang, Q., Guo, R., Ma, Q., Sun, Q., Fan, Y., Xie, Y., Yang, Z., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15457-9 · Cited by 409
The role of histone modifications: from neurodevelopment to neurodiseases
Park, J., Lee, K., Kim, K., & Yi, S.-J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01078-9 · Cited by 297
Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia
Martel, J. C., & Gatti McArthur, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01003 · Cited by 229
Neurobiology of Schizophrenia: A Comprehensive Review
Luvsannyam, E., Jain, M. S., Pormento, M. K. L., Siddiqui, H., Balagtas, A. R. A., Emuze, B. O., & Poprawski, T. (2022) · Cureus · doi:10.7759/cureus.23959 · Cited by 127
Metadata
- Authors
- Kesby, J., Eyles, D., McGrath, J., & Scott, J.
- Venue
- Translational Psychiatry
- Published
- 2018-01-31
- Volume
- 8
- Issue
- 1
- Pages
- 30-30
- ISSN
- 2158-3188 (ISSN-L)
- OpenAlex
- W2795334944
- Cited by
- 352
- References
- 117
- FWCI
- 23.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.